Second‐line systemic therapy for metastatic colorectal cancer

BACKGROUND: The therapeutic management of people with metastatic colorectal cancer (CRC) who did not respond to first‐line treatment represents a formidable challenge. OBJECTIVES: To determine the efficacy and toxicity of second‐line systemic therapy in people with metastatic CRC. SEARCH METHODS: We...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cochrane Database Syst Rev
Egile Nagusiak: Mocellin, Simone, Baretta, Zora, Roqué i Figuls, Marta, Solà, Ivan, Martin‐Richard, Marta, Hallum, Sara, Bonfill Cosp, Xavier
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2017
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464923/
https://ncbi.nlm.nih.gov/pubmed/28128439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006875.pub3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak